Literature DB >> 15256314

Study of glycated amino acid elimination reaction for an improved enzymatic glycated albumin measurement method.

Takuji Kouzuma1, Yumiko Uemastu, Tomomi Usami, Shigeyuki Imamura.   

Abstract

BACKGROUND: In order to improve enzymatic glycated albumin measurement, we studied the endogenous glycated amino acid elimination reaction and the new bromocresolpurple (BCP) method for albumin measurement.
METHODS: In the assay, endogenous glycated amino acids are first eliminated by oxidation by ketoamine oxidase. Second, glycated albumin is hydrolyzed to glycated amino acids by proteinase digestion, and glycated amino acids are oxidized to produce hydrogen peroxide, which is quantitatively measured. Third, albumin is measured by the new BCP method. Finally, glycated albumin value is calculated as the percentage of glycated albumin in total albumin.
RESULTS: Glycated amino acid concentrations in prepared total parenteral nutrition products were increased in direct proportion to storage time and temperature. The glycated amino acid elimination reaction using ketoamine oxidase may be able to eliminate more than 15 mmol/l glycated amino acids. The glycated albumin values of samples calculated from the albumin concentrations using the new BCP method accorded with those calculated with the HPLC method. Fundamental performances (linearity, dilution test, analytical recovery, within-run and between-run CVs, interference study) of the present method were good. Detection of glycated albumin by the present method was significantly correlated with detection of glycated albumin by the high-performance liquid chromatography method (r(p) = 0.995).
CONCLUSIONS: This new improved method is free of interference by endogenous glycated amino acids and is unaffected by albumin concentration, and enables more accurate analysis of glycated albumin.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15256314     DOI: 10.1016/j.cccn.2004.02.019

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  36 in total

1.  Basic performance of an enzymatic method for glycated albumin and reference range determination.

Authors:  Takuji Kohzuma; Tamotsu Yamamoto; Yumiko Uematsu; Zak K Shihabi; Barry I Freedman
Journal:  J Diabetes Sci Technol       Date:  2011-11-01

2.  Evaluation of glycated albumin and microalbuminuria as early risk markers of nephropathy in type 2 diabetes mellitus.

Authors:  Suresh Babu Kondaveeti; Kumaraswamy D; Shishir Mishra; Aravind Kumar R; I Anand Shaker
Journal:  J Clin Diagn Res       Date:  2013-07-01

3.  Ex vivo instability of glycated albumin: A role for autoxidative glycation.

Authors:  Joshua W Jeffs; Shadi Ferdosi; Hussein N Yassine; Chad R Borges
Journal:  Arch Biochem Biophys       Date:  2017-07-13       Impact factor: 4.013

Review 4.  Recent topics in chemical and clinical research on glycated albumin.

Authors:  Yuki Ueda; Hideyuki Matsumoto
Journal:  J Diabetes Sci Technol       Date:  2015-01-21

5.  Influences of Anemia, Kidney Disease, Thyroid Dysfunction, and Liver Disease on the Ratio of Glycated Albumin to Hemoglobin A1c.

Authors:  Hiroyasu Miyamoto; Xinran Tao; Takuji Kohzuma; Akihiro Ohnishi
Journal:  J Diabetes Sci Technol       Date:  2018-04-05

6.  Effects of maximal atorvastatin and rosuvastatin treatment on markers of glucose homeostasis and inflammation.

Authors:  Nuntakorn Thongtang; Masumi Ai; Seiko Otokozawa; Thomas V Himbergen; Bela F Asztalos; Katsuyuki Nakajima; Evan Stein; Peter H Jones; Ernst J Schaefer
Journal:  Am J Cardiol       Date:  2011-02-01       Impact factor: 2.778

Review 7.  Advantages and pitfalls of fructosamine and glycated albumin in the diagnosis and treatment of diabetes.

Authors:  Elisa Danese; Martina Montagnana; Antonio Nouvenne; Giuseppe Lippi
Journal:  J Diabetes Sci Technol       Date:  2015-01-14

8.  Serum glycated albumin: Potential use as an index of glycemic control in diabetic dogs.

Authors:  T Sako; A Mori; P Lee; T Sato; H Mizutani; T Takahashi; Y Kiyosawa; H Tazaki; T Arai
Journal:  Vet Res Commun       Date:  2008-12-03       Impact factor: 2.459

9.  A review of glycated albumin as an intermediate glycation index for controlling diabetes.

Authors:  H Vernon Roohk; Asad R Zaidi
Journal:  J Diabetes Sci Technol       Date:  2008-11

10.  Comparison of the effects of maximal dose atorvastatin and rosuvastatin therapy on cholesterol synthesis and absorption markers.

Authors:  Thomas M van Himbergen; Nirupa R Matthan; Nancy A Resteghini; Seiko Otokozawa; Masumi Ai; Evan A Stein; Peter H Jones; Ernst J Schaefer
Journal:  J Lipid Res       Date:  2008-11-30       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.